Stockscreener 앱 받기
1.28
0.79%
0.01
시간 외 거래:
1.28
전일 마감가:
$1.27
열려 있는:
$1.2709
하루 거래량:
44,608
Relative Volume:
0.09
시가총액:
$44.55M
수익:
$2.91M
순이익/손실:
$-220.40M
주가수익비율:
-0.3516
EPS:
-3.64
순현금흐름:
$-176.15M
1주 성능:
+0.79%
1개월 성능:
+10.34%
6개월 성능:
-25.58%
1년 성능:
-88.97%
1일 변동 폭
$1.27
$1.28
1주일 범위
$1.26
$1.29
52주 변동 폭
$0.92
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
명칭
Igm Biosciences Inc
전화
650-965-7873
주소
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
IGMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
1.28 | 76.44M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-01-10 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-10-01 | 다운그레이드 | Truist | Buy → Hold |
| 2024-02-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | 재개 | Jefferies | Buy |
| 2022-10-17 | 개시 | JP Morgan | Neutral |
| 2022-08-29 | 개시 | BofA Securities | Buy |
| 2021-12-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2021-08-26 | 개시 | Morgan Stanley | Overweight |
| 2021-01-29 | 개시 | RBC Capital Mkts | Outperform |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-22 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-07-17 | 개시 | Robert W. Baird | Outperform |
| 2020-07-01 | 개시 | H.C. Wainwright | Buy |
| 2020-05-28 | 개시 | SunTrust | Buy |
| 2020-04-22 | 개시 | Wedbush | Outperform |
| 2019-10-14 | 개시 | Guggenheim | Buy |
| 2019-10-14 | 개시 | Jefferies | Buy |
| 2019-10-14 | 개시 | Piper Jaffray | Overweight |
| 2019-10-14 | 개시 | Stifel | Buy |
모두보기
Igm Biosciences Inc 주식(IGMS)의 최신 뉴스
What analysts say about IGM Biosciences Inc. stockStrong return on investment - Autocar Professional
What drives IGM Biosciences Inc. stock priceExtraordinary profit generation - Autocar Professional
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $5.50 Consensus PT from Brokerages - MarketBeat
Is IGM Biosciences Inc. a good long term investmentConsistently exceptional gains - jammulinksnews.com
Stockholder Sues IGM Biosciences for Alleged SEC Violations - Bloomberg Law News
IGM Biosciences Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional
IGM Biosciences (NASDAQ:IGMS) Stock Price Down 5.9%Here's What Happened - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
Fierce Biotech Layoff Tracker 2025: Sail shrinks crew again; Sarepta lays off 500 staffers - Fierce Biotech
IGM Biosciences (NASDAQ:IGMS) Trading Down 5.9% – Here’s Why - Defense World
Why IGM Biosciences Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru
Concentra Group (CON) to Acquire IGM Biosciences - MSN
What makes IGM Biosciences Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser
How IGM Biosciences Inc. stock performs during market volatilityFree Access to Group - Newser
In Brief: Concentra Snaps Up Struggling IGM Biosciences In Latest Biotech Deal - insights.citeline.com
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: GMS, IGMS, MRC, and GRYP - The Malaysian Reserve
IGM Biosciences to be acquired by Concentra - The Pharma Letter
Regeneron bispecific approved for myeloma; Concentra to buy IGM - BioPharma Dive
Concentra to acquire IGM Biosciences for $1.247 per share plus CVR - Investing.com Nigeria
Concentra Biosciences, LLC agreed to acquire IGM Biosciences, Inc. for $76.3 million. - MarketScreener
IGM Biosciences Shares Surge on Takeover Agreement with Concentra - MSN
IGM Biosciences Gets Snapped Up In Concentra Deal - Finimize
IGM Biosciences stock soars after Concentra acquisition deal - Investing.com
IGM Biosciences Enters Definitive Merger Agreement with Concentra Biosciences for Acquisition - Nasdaq
IGM Biosciences stock soars after Concentra acquisition deal By Investing.com - Investing.com UK
IGM Biosciences, Inc.(NasdaqGS: IGMS) dropped from Russell 3000 Index - MarketScreener
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Recommendation of "Reduce" by Brokerages - MarketBeat
Igm biosciences CFO Tahir Misbah sells $1,825 in stock - Investing.com
Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace
IGM Biosciences price target lowered to $1 from $2 at Truist - Yahoo Finance
IGM Biosciences Faces Nasdaq Non-Compliance Notice - TipRanks
Truist Revises IGM Biosciences (IGMS) Price Target to $1 | IGMS Stock News - GuruFocus
Truist Cuts Price Target on IGM Biosciences to $1 From $2, Keeps Hold Rating - MarketScreener
Igm Biosciences Inc (IGMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.91%
0.25%
자본화:
|
볼륨(24시간):